Medicare Coverage for Osteoarthritis: Conservative Management Before Surgery

Osteoarthritis (OA) is the most common joint disease in the United States, affecting more than 32 million Americans — and it is overwhelmingly a condition of older adults. More than 70% of Americans over 65 show X-ray evidence of OA in at least one joint. The knees, hips, hands, and spine are the most commonly affected sites.

For Medicare beneficiaries, osteoarthritis creates two separate financial decisions: how to manage the condition conservatively, and when (and whether) to proceed to joint replacement surgery. This guide focuses on the first decision — the conservative management phase — including exactly what Medicare covers, what it excludes, and why the documentation of your conservative treatment matters enormously if you ever need surgery.

What Osteoarthritis Is (and Why It’s Different from Rheumatoid Arthritis)

Osteoarthritis is mechanical wear-and-tear damage to joint cartilage. As cartilage thins and breaks down over decades of use, bones begin to rub directly against each other, causing pain, stiffness, swelling, and eventually reduced range of motion. Risk factors include age, obesity, prior joint injury, occupational stress, and genetics.

This is fundamentally different from rheumatoid arthritis (RA), which is an autoimmune disease driven by systemic inflammation. OA is treated with mechanical and symptomatic interventions — physical therapy, weight reduction, activity modification, anti-inflammatory medications, and injections. RA is treated with disease-modifying drugs and biologics. The Medicare coverage frameworks are correspondingly different. For RA, see Medicare Coverage for Rheumatoid Arthritis and Biologics.

The Conservative Management Pathway

Before joint replacement surgery is considered, Medicare — and every major orthopedic guideline — expects patients to try conservative management. A typical sequence for knee OA looks like this:

1. Diagnosis and imaging — X-rays to confirm and stage OA
2. Physical therapy and exercise — strengthening the muscles around the joint to reduce load
3. Weight management — the most evidence-based intervention for knee OA
4. Assistive devices — cane, walker, unloading knee brace
5. Topical and oral anti-inflammatory medications — NSAIDs, topical diclofenac, duloxetine
6. Corticosteroid injections — for acute flares and when PT/medications are insufficient
7. Further evaluation — MRI if surgical planning is needed, or to rule out other causes

Conservative management may continue for months or years. For mild to moderate OA, it can remain effective indefinitely. For severe OA with significant structural damage and quality-of-life impairment, it eventually fails, at which point joint replacement becomes appropriate.

The critical point: if you have Medicare Advantage, your plan’s prior authorization for joint replacement will ask for documentation of conservative management. Original Medicare does not require prior authorization for surgery, but your surgeon’s documentation of failed conservative treatment forms part of the medical necessity record.

Diagnostic Imaging Under Medicare Part B

The diagnostic workup for OA is covered under Medicare Part B at 80% of the Medicare-approved amount after your annual deductible ($283 in 2026). You pay the remaining 20% coinsurance.

X-rays of the affected joint: The standard diagnostic tool for OA. Weight-bearing X-rays of the knee, hip X-rays, and hand/wrist films confirm cartilage loss (seen as joint space narrowing), bone spurs (osteophytes), and subchondral sclerosis. Typical cost: $50–$150; your 20% share is $10–$30.

MRI of the affected joint: Not always needed for OA diagnosis (X-rays suffice for most cases), but ordered when the clinical picture is unclear, when there is concern about a meniscal tear or other internal derangement, or when surgical planning requires detailed anatomy. Typical Medicare-approved amount: $350–$600; your 20% share is $70–$120.

Ultrasound-guided joint evaluation: Used by rheumatologists and orthopedists to evaluate soft tissue, guide injections precisely, or confirm effusion (fluid buildup). Covered under Part B.

Blood tests: If your physician needs to rule out inflammatory arthritis (RA, gout, pseudogout), blood tests (CBC, CMP, uric acid, RF, anti-CCP) are covered as clinical laboratory tests at zero cost-sharing — no deductible, no coinsurance.

Physical Therapy Under Medicare Part B

Physical therapy is the cornerstone of OA conservative management, and Medicare Part B covers it with no hard annual visit cap.

How it works: Part B pays 80% of the Medicare-approved amount after the $283 annual Part B deductible. You pay 20% coinsurance. The average per-visit Medicare-approved amount for outpatient PT is approximately $90–$130, making your 20% share roughly $18–$26 per visit.

No therapy cap: Congress permanently eliminated the $1,940 annual therapy cap in 2018. However, when your cumulative annual therapy charges exceed approximately $2,480 (the 2026 KX modifier threshold), your therapist must add a KX modifier to each claim certifying that continued treatment is medically necessary. If your records support it, coverage continues without interruption.

What PT covers for OA:

• Strengthening exercises for muscles around the affected joint (quadriceps strengthening for knee OA significantly reduces joint load)
• Range-of-motion exercises
• Manual therapy techniques
• Aquatic therapy (pool-based PT, covered if provided by a licensed PT in a qualifying setting)
• Patient education on activity modification and joint protection
• Home exercise program instruction

Occupational therapy: If OA limits your ability to perform daily activities — dressing, cooking, gripping tools — OT addresses functional adaptations and assistive device training. Covered at the same Part B 80/20 split with its own KX modifier threshold.

Maintenance therapy: Under the 2013 Jimmo v. Sebelius settlement, Medicare covers maintenance therapy — ongoing PT to prevent functional decline, not just to achieve measurable improvement. This matters for OA patients who have stabilized but need periodic PT to maintain function.

Corticosteroid (Steroid) Joint Injections: What Medicare Covers

When physical therapy and medications are insufficient to control OA pain, corticosteroid injections are the next step. Medicare Part B covers these when administered by a physician or other qualified provider.

How corticosteroid injections work: A corticosteroid (such as triamcinolone, methylprednisolone, or betamethasone) is injected directly into the affected joint — typically the knee, hip, shoulder, or small hand joints — with or without ultrasound guidance. The steroid reduces local inflammation and synovitis, providing pain relief that can last from a few weeks to several months.

What Medicare covers:

• The physician’s injection fee (CPT codes 20610 for large joint like knee or hip; 20600 for small joint)
• Ultrasound guidance if used for precise needle placement (CPT 76942)
• The corticosteroid medication itself (when physician-administered, it’s billed as a drug incident to the injection, covered under Part B)

Cost-sharing: 80/20 split under Part B after the annual deductible. A corticosteroid knee injection in an outpatient physician office typically runs $150–$300 total; your 20% share is $30–$60. If performed in a hospital outpatient department, facility fees apply and costs are higher.

Frequency limits: No rigid Medicare-specified frequency limit exists, but medical guidelines recommend no more than 3–4 large-joint corticosteroid injections per year in the same joint. Your physician must document medical necessity for each injection; repeated injections without documented ongoing benefit may face claim scrutiny.

Hyaluronic Acid (Viscosupplementation): The Medicare Exclusion

This is one of the most important Medicare-specific facts for OA patients: Medicare does not cover hyaluronic acid (viscosupplementation) injections for osteoarthritis.

Viscosupplementation involves injecting hyaluronic acid — a substance that mimics the natural lubricant in joint fluid — into the knee (or occasionally hip). Brands include Synvisc, Orthovisc, Euflexxa, Hyalgan, and Supartz. Courses consist of 1–5 injections given over several weeks.

Why Medicare excludes viscosupplementation: In 2008, CMS issued a non-coverage determination concluding that the evidence did not demonstrate that viscosupplementation was reasonable and necessary for Medicare purposes. The clinical evidence has remained mixed: a 2012 NEJM analysis and subsequent Cochrane reviews found only small, clinically uncertain benefits over placebo. Some professional societies (American Academy of Orthopaedic Surgeons) now give viscosupplementation a “cannot recommend” grade; others still support it for certain patients.

What this means for you: If your orthopedist recommends viscosupplementation, you will pay 100% out of pocket. A typical 3–5 injection course costs $700–$1,500 out of pocket depending on the brand. Before agreeing, confirm the cost in writing and ask your physician about the evidence. If you want to try it despite the cost, some states may have Medicare Advantage plans that cover it — check your specific plan documents.

The practical impact: Many patients and physicians don’t realize Medicare excludes viscosupplementation until they receive a large bill. Understanding this in advance lets you make an informed decision.

Weight Management: The Most Evidence-Based OA Intervention

For knee OA specifically, weight loss is the single most effective conservative intervention for reducing pain and slowing disease progression. Each pound of body weight translates to roughly 4 pounds of force across the knee joint during normal walking. A 10-pound weight loss reduces knee load by 40 pounds per step.

Medicare covers several pathways to support weight loss in OA patients:

Intensive Behavioral Therapy for Obesity (IBT): If your BMI is ≥30, Medicare Part B covers IBT at zero cost-sharing — no deductible, no coinsurance. IBT provides 22 individual face-to-face sessions in the first year (one per week for months 1–6 if weight loss goals are met, then monthly for months 7–12), and subsequent sessions if you maintain the minimum weight loss benchmark. This is a highly valuable, often underused Medicare benefit.

GLP-1 medications for diabetes or cardiovascular disease: Semaglutide (Ozempic/Wegovy) and related GLP-1 receptor agonists produce significant weight loss as a secondary effect. If you have type 2 diabetes or established cardiovascular disease, Part D covers these medications, and the resulting weight loss directly benefits OA symptoms. For patients whose only indication is obesity, coverage has expanded but varies by plan. See Medicare Coverage for Ozempic, Wegovy, and Weight Loss Drugs.

Bariatric surgery: For patients with severe obesity (BMI ≥35 with comorbidities), Medicare Part A covers bariatric surgery (laparoscopic gastric bypass, sleeve gastrectomy) when performed in a Medicare-approved facility. The resulting weight loss is the most durable treatment for knee OA in obese patients.

Assistive Devices and Bracing: Medicare DME Coverage

Medicare Part B covers durable medical equipment (DME) for OA when prescribed by your physician. DME is covered at 80% of the Medicare-approved amount after the Part B deductible — but only when purchased through a Medicare-enrolled DME supplier.

Covered DME for OA:

• Standard cane or quad cane: Covered when medically necessary for ambulatory assistance ($15–$40 approved amount; your 20% = $3–$8)
• Walker (standard or wheeled): Covered when a cane is insufficient ($60–$120 approved amount; your 20% = $12–$24)
• Knee orthosis (unloading brace): A custom-fitted or off-the-shelf unloading knee brace for medial or lateral compartment OA may be covered as a lower-limb orthotic if medically prescribed and documented. Coverage requires a physician’s prescription with documented medical necessity.
• TENS unit: A transcutaneous electrical nerve stimulation device may be covered for chronic pain management under certain circumstances, though coverage is limited and varies by local Medicare contractor.

What is NOT covered:

• Hot and cold therapy devices (heating pads, ice packs, paraffin baths)
• Shoe insoles and arch supports (unless specifically fitted as orthotics by a qualified provider)
• Exercise equipment for home use (stationary bikes, resistance bands)
• Swimming pool memberships for aquatic therapy

Part D Medications for Osteoarthritis

Medications for OA symptom management are covered under Medicare Part D (your drug plan). Coverage and cost-sharing vary by plan tier. For a primer on how Part D works, see Medicare Part D Explained: Drug Coverage, Tiers, and Costs.

NSAIDs (non-steroidal anti-inflammatory drugs):

• Oral NSAIDs (ibuprofen, naproxen, diclofenac, meloxicam, celecoxib): All available as generics. Tier 1–2 on most Part D formularies; typical monthly cost $5–$30 after copay. Note: chronic NSAID use carries GI and cardiovascular risks that are heightened in older adults. Concurrent proton pump inhibitor (PPI) use is often recommended and is also covered under Part D.
• Topical diclofenac (Voltaren gel, generic diclofenac sodium 1% gel): Available over the counter since 2020, so not covered by Part D for OA. However, if prescribed at higher concentrations (2% or 3%) compounded formulations, or for other indications, Part D coverage may apply. The OTC version is your most affordable option at $15–$25 per tube.

Duloxetine (Cymbalta): An SNRI antidepressant with an FDA approval for chronic musculoskeletal pain. Generic duloxetine is inexpensive (Tier 1–2, $5–$15/month) and is frequently used for OA pain that has a central sensitization component. Covered under Part D.

Acetaminophen: Available OTC, not covered by Part D. Despite modest efficacy for OA pain, it remains widely recommended for its favorable safety profile in older adults compared to NSAIDs.

Tramadol and other opioid analgesics: Part D covers tramadol and schedule II opioids, but their use for chronic OA pain is generally not recommended and carries significant risks. Coverage is subject to quantity limits and prior authorization on many plans.

Supplements (glucosamine, chondroitin): Not covered by Part D. Clinical trial evidence (GAIT trial) showed no benefit beyond placebo for most patients.

Platelet-Rich Plasma (PRP): Not Covered by Medicare

Platelet-rich plasma (PRP) injections — which use your own blood, processed to concentrate platelets and growth factors, then injected into the joint — have gained significant popularity for OA treatment. Medicare does not cover PRP for osteoarthritis. There is no approved National Coverage Determination for PRP in OA, and the clinical evidence remains insufficient to meet Medicare’s medical necessity standard.

A typical PRP injection costs $500–$2,000 out of pocket per injection. Some patients receive a series of 3 injections. Proceed only with clear-eyed awareness that this is entirely an out-of-pocket expense with uncertain effectiveness.

How Medigap vs. Medicare Advantage Affects Your OA Costs

Original Medicare + Medigap Plan G: The most cost-predictable path. Plan G covers the Part B 20% coinsurance for all covered services — PT, imaging, injections, physician visits — leaving only the $283 annual Part B deductible as your out-of-pocket exposure for the entire year’s OA care. Long-term conservative management involving regular PT sessions and periodic injections becomes financially manageable. See Medigap Plans Compared: Which Supplement Is Right for You? for a complete comparison of supplement options.

Medicare Advantage: Plans cover OA conservative management but with important differences:

• In-network restrictions: You must use in-network orthopedists, PT clinics, and imaging centers — or pay higher out-of-network rates.
• Prior authorization: Some MA plans require PA for MRI, for extended PT courses, or for corticosteroid injections. This adds administrative friction but rarely changes clinical decisions permanently.
• Out-of-pocket maximums: MA’s annual OOP cap ($3,300–$9,200 in 2026) protects against catastrophic costs during intensive therapy periods.
• Additional benefits: Some MA plans offer expanded PT visits, gym memberships (Silver Sneakers), or over-the-counter allowances that can be applied to OA management aids.

For a detailed cost comparison, see Medicare Supplement vs. Medicare Advantage: True Cost Comparison.

The Documentation Requirement: Why Your Conservative Management Record Matters

If you eventually need joint replacement surgery, the documentation of your conservative management period is important for two reasons:

1. Medical necessity for surgery: Both Medicare and Medicare Advantage plans look for evidence that surgery is indicated by failure of conservative treatment, not as a first resort. Your orthopedic surgeon’s records documenting persistent pain and functional limitation despite PT, injections, and medications strengthen the medical necessity record.

2. Medicare Advantage prior authorization: Most MA plans require documentation of at least 3–6 months of conservative management before approving elective joint replacement. If your records are incomplete, the PA process takes longer and may require supplemental documentation.

Practical advice: Ask your orthopedist or primary care physician to explicitly document in each visit note:

• Duration and severity of OA symptoms
• Treatments tried, duration, and response
• Current functional limitations (ability to walk distances, climb stairs, perform daily activities)
• The clinical reasoning for progression or change in treatment

This creates a clear audit trail that supports surgery authorization when the time comes.

For a full guide to joint replacement surgery costs and coverage, see Medicare Coverage for Hip and Knee Replacement Surgery.

Cost Summary: Conservative OA Management Under Medicare

With Medigap Plan G: All Part B cost-sharing above (except the $283 deductible) is eliminated. Your total annual out-of-pocket for conservative OA care is close to zero after the deductible, regardless of how many PT visits or injections you need.

For strategies to minimize costs, see Medicare Savings Programs: Extra Help and Low-Income Subsidies and Healthcare Costs in Retirement: What to Budget.

Step-by-Step Planning Guide

If you have Medicare and are managing osteoarthritis:

1. Confirm your Part B enrollment: Conservative OA management is almost entirely under Part B. Make sure you are enrolled and that your Part B is active.

2. Get the diagnosis documented: Your physician should document OA with appropriate ICD-10 codes (M17.x for knee OA, M16.x for hip OA) — not just “joint pain” — so that all downstream treatments are clearly linked to the correct diagnosis.

3. Start physical therapy early: PT is the best-evidenced conservative intervention and costs far less than injections or surgery. A referral to an experienced musculoskeletal PT early in your management is high-value.

4. Ask about the IBT benefit: If your BMI is ≥30, specifically ask your primary care doctor to enroll you in the Medicare Intensive Behavioral Therapy for Obesity program. Weight loss directly reduces OA progression.

5. Understand the viscosupplementation exclusion before agreeing to it: If your orthopedist recommends hyaluronic acid injections, ask for the cost up front — this is not covered by Medicare.

6. Document everything: Keep records of your PT attendance, injection dates, medication trials, and physician notes. This record supports both your clinical management and any future prior authorization for surgery.

7. Review your supplement coverage: If you are managing OA with frequent PT and periodic injections, Medigap Plan G eliminates the 20% coinsurance on all these services. Run the numbers: if you attend 30 PT visits and have 2 injections per year, you are paying $600–$900 per year in coinsurance that a Medigap premium might be less expensive than.

Frequently Asked Questions

Does Medicare cover physical therapy for osteoarthritis? Yes. Medicare Part B covers outpatient physical therapy for OA with 80/20 cost-sharing (you pay 20% after the $283 annual deductible). There is no hard annual visit cap. If you have Medigap Plan G, the 20% coinsurance is covered.

Does Medicare cover hyaluronic acid (Synvisc, Orthovisc) injections? No. Medicare explicitly does not cover viscosupplementation injections for osteoarthritis. You would pay 100% of the cost out of pocket. This is one of the most common billing surprises in OA management for Medicare beneficiaries.

Are cortisone (corticosteroid) injections covered by Medicare? Yes. Corticosteroid joint injections are covered under Part B when administered by a physician. The injection fee, any ultrasound guidance, and the steroid medication itself are covered at 80% (you pay 20%).

Does Medicare cover knee braces for osteoarthritis? Custom and off-the-shelf unloading knee braces may be covered as DME under Part B with a physician prescription and medical necessity documentation. Standard braces purchased without a prescription are not covered.

Does Medicare Advantage cover the same OA treatments? Yes, but with network restrictions and possible prior authorization requirements for imaging, extended PT, or surgery. The coverage itself is equivalent to Original Medicare; the administrative and network rules differ.

What documentation do I need if I want joint replacement surgery eventually? Your surgeon and physician should document the duration of symptoms, severity of functional limitation, and all conservative treatments tried (PT with dates attended, injection dates and responses, medications trialed). Most Medicare Advantage plans require 3–6 months of documented conservative management before approving elective joint replacement surgery.